Inflammatory Cytokines in the BAL of Patients With ARDS: Persistent Elevation Over Time Predicts Poor Outcome

doi:10.1378/chest.108.5.1303

Chest

Volume 108, Issue 5, November 1995, Pages 1303-1314

https://doi.org/10.1378/chest.108.5.1303 Get rights and content

Background

Inflammatory cytokines (ICs) are important modulators of injury and repair. ICs have been found to be elevated in the BAL of patients with both early and late ARDS. We tested the hypothesis that recurrent injury to the alveolocapillary barrier and amplification of intra-alveolar fibroproliferation observed in nonresolving ARDS is related to a persistent inflammatory response. For this purpose, we obtained serial measurements of BAL IC and correlated these levels with lung injury score (LIS), BAL indexes of endothelial permeability (albumin, total protein [TP]), and outcome.

Methods

We prospectively studied 27 consecutive patients with severe medical ARDS. Using enzyme-linked immunosorbent assay methods, levels of tumor necrosis factor-α (TNF-α) and interleukins (IL) 1p, 2, 4, 6, and 8 were measured at frequent intervals in both plasma and BAL. In 22 patients, bilateral BAL was obtained on day 1 of ARDS and at weekly intervals when possible. Right and left BALs were analyzed separately for IC levels, total cell count and differential, albumin, TP, and quantitative bacterial cultures.

Results

On day 1 of ARDS, the 10 nonsurvivors had significantly higher (p=0.0002) BAL TNF-α, IL-1ß, IL-6, and IL-8 levels, which remained persistently elevated over time, indicating a continuous injury process. In contrast, the 12 survivors had a lesser elevation and a rapid reduction over time. Initial BAL IL-2 and IL-4 levels were significantly higher in patients with sepsis (p=0.006); both increased over time in survivors and nonsurvivors. BAL levels of TNF-α, IL-1ß, IL-6, and IL-8 correlated with BAL albumin and TP concentrations but not with LIS or ratio of arterial oxygen tension to inspired oxygen concentration. BAL:plasma ratios were elevated for all measured cytokines, suggesting a pulmonary origin. On day 1 of ARDS, nonsurvivors had significantly higher (p=0.04) BAL: plasma ratios for TNF-α, IL-1ß, IL-6, and IL-8. Over time, BAL:plasma ratios for TNF-α, 1L-1ß and IL-6 remained elevated in nonsurvivors and decreased in survivors.

Conclusions

Our findings indicate that an unfavorable outcome in ARDS is associated with an initial, exaggerated, pulmonaiy inflammatory response that persists unabated over time. Plasma IC levels parallel changes in BAL IC levels. The BAL:plasma ratio results suggest, but do not prove, a pulmonary origin for IC production. BAL TNF-α, IL-1ß, and IL-8 levels correlated with BAL indices of endothelial permeability. In survivors, reduction in BAL IC levels over time was associated with a decline in BAL albumin and TP levels, suggesting effective repair of the endothelial surface. These findings support a causal relationship between degree and duration of lung inflammation and progression of fibroproliferation in ARDS.

Section snippets

Patients

The study was conducted between January 1992 and May 1993 at the Medical ICU of the Regional Medical Center and The University of Tennessee Medical Center, Memphis. The protocol was approved by The University of Tennessee institutional review board, and informed consent was obtained before patients were entered into the study. We prospectively studied 27 consecutive patients who developed ARDS. Patients entered the study within 24 h of developing ARDS.

In 22 of these 27 patients, bilateral BAL

Clinical Variables at Entrance

Twenty-seven patients entered the study: 16 were male and 11 were female. The mean (±SD) age was 47±13 years. Mean APACHE II score on hospital admission was 24±9, and predicted mortality was 43±25%. Mean LIS was 2.85±0.6 with all but six patients having an LIS greater than 2.5. ARDS was caused by a direct lung injury in 18 patients, including 16 with pneumonia and 2 with chemical aspiration. Indirect injuries leading to ARDS (nine patients) included five extrapulmonary sepsis, one pancreatitis,

Discussion

Intercellular communication through cytokine networking is essential for tissue homeostasis and provides a defense against infectious and noninfectious agents. Tissue response to insults is similar regardless of the tissue involved and manifests with two sequential and interconnected steps, inflammation and fibroproliferation. These cellular responses are regulated by a complex interaction among inflammatory, fibrogenic, and antifibrogenic cytokines, with effects on the surrounding

Conclusions

By measuring BAL and plasma IC levels at the onset of ARDS and throughout the disease, we have provided data indicating that the degree of initial pulmonary inflammatory response sets the pace for the evolution of ARDS and may ultimately determine patient outcome. This agrees with prior studies that found an association between progression of ARDS and extent of initial lung injury in the form of alveolar denudation, basement membrane destruction, vascular permeability, and quantity of

Acknowledgment

The authors wish to thank Melissa Shelby for meticulous data collection, and Dr. David Armbruster for editorial review of the manuscript.

References (72)

EliasJA et al.
Cytokine networks in the regulation of inflammation and fibrosis in the lung
Chest
(1990)
BittermanPB et al.
Fibroproliferative disorders
Chest
(1991)
BoneRC et al.
Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
Chest
(1992)
MeduriGU et al.
Fibroproliferative phase of ARDS: clinical findings and effects of corticosteroids
Chest
(1991)
MeduriGU et al.
Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS: plasma IL-1 and IL-6 are consistent and efficient predictors of outcome over time
Chest
(1995)
MeduriGU et al.
Plasma and BAL cytokine response to corticosteroid treatment in late ARDS
Chest
(1995)
DonnellySC et al.
Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups
Lancet
(1993)
RobertsDJ et al.
Tumour necrosis factor and adult respiratory distress syndrome
Lancet
(1989)
MillarAB et al.
Tumour necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome
Lancet
(1989)
RaponiG et al.
Tumor necrosis factor in serum and in bronchoalveolar lavage of patients at risk for the adult respiratory distress syndrome
J Crit Care
(1992)

JorensPG et al.

Interleukin 8 (IL-8) in the bronchoalveolar lavage fluid from patients with the adult respiratory distress syndrome (ARDS) and patients at risk for ARDS

Cytokine

(1992)

HeffnerJE et al.

Clinical predictors of prolonged translaryngeal intubation in patients with the adult respiratory distress syndrome

Chest

(1990)

SinclairDG et al.

Pulmonary endothelial permeability in patients with severe lung injury

Chest

(1994)

WaageA et al.

Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease

Lancet

(1987)

CalandraT et al.

High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines

Am J Med

(1991)

HackCE et al.

Increased plasma levels of interleukin-6 in sepsis

Blood

(1989)

MeduriGU

Late ARDS

New Horizons

(1993)

KingRJ et al.

Regulation of lung cell proliferation by polypeptide growth factors

Am J Physiol

(1989)

MeduriGU et al.

Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS: patterns of response and predictors of outcome

Chest

(1994)

MeduriGU et al.

The fibroproliferative phase of late ARDS

Semin Respir Infect

(1995)

MeadeP et al.

Temporal patterns of hemodynamics, oxygen transport, cytokine activity, and complement activity in the development of adult respiratory distress syndrome after severe injury

J Trauma

(1994)

KnausWA et al.

Prognosis in acute organ system failure

Ann Surg

(1985)

MurrayJF et al.

An expanded definition of the adult respiratory distress syndrome

Am Rev Respir Dis

(1988)

FowlerAA et al.

Adult respiratory distress syndrome: prognosis after onset

Am Rev Respir Dis

(1985)

MeduriGU et al.

Causes of fever and pulmonary densities in patients with clinical manifestations of ventilator-associated pneumonia

Chest

(1994)

MeduriGU et al.

The standardization of bronchoscopic techniques for ventilator-associated pneumonia

Chest

(1992)

GrassiG et al.

Production of monoclonal antibodies against interleukin-lα and 1ß: development of two enzyme immunometric assays (EIA) using acetylcholinesterase and their application to biological media

J Immunol Methods

(1989)

SokalRR et al.

Biometry: the principles and practice of statistics in biological research

(1981)

KovacsEJ et al.

Fibrogenic cytokines and connective tissue production

FASEB J

(1994)

CeramiA